Uncategorized
Ivantis raises $46.5 million in Series B funding
Ivantis has secured an additional $14 million from Vertex Ventures and GBS Ventures in the final close of its Series B financing, bringing the total amount raised to $46.5 million, according to a press release. The funds will support the company’s three large ongoing clinical trials, including the U.S. pivotal trial of the Hydrus microstent.